Copenhagen, 21 September 2018
The Danish company STENOCARE A/S (“STENOCARE” or “the Company”) was founded in 2017 with a vision to help patients in pain to a better quality of life. The Company is the first to sell approved medical cannabis oils in Denmark.
The Company has now been approved for listing on Spotlight Stock Market and announces that the subscription in the Company’s share issue of approx. DKK 18.6 million will commence on Monday, the 24th of September 2018. The main purpose of the new share issue is to finance the Company’s planned growth, which includes the establishment of a production facility to cultivate and manufacture its own finished medical cannabis products for patients in Denmark and Europe.

